Nano-sized titanium dioxide particles (TiO
2) are widely used in cosmetics, sunscreens and food additives. We previously reported that topical application of non-coated rutile type TiO
2 did not exhibit a promoting effect on ultraviolet B-initiated skin carcinogenesis in rats, and that this was likely due to lack of penetration of TiO
2 into the epidermis. In the present study, we examined the promoting effect of silicone coated TiO
2 (sTiO
2) suspended in silicone oil and non-coated TiO
2 (ncTiO
2) suspended in Pentalan 408
on a two-stage skin chemical carcinogenesis model: sTiO
2 suspended in silicon oil forms smaller particles than ncTiO
2 suspended in Pentalan because of the smaller sizes of aggregates formed. The model used skin carcinogenesis-sensitive human c-Ha-ras proto-oncogene transgenic mice (rasH2) and rats (Hras128) and their wild-type counterparts and CD-1 mice to test the effects of topical application of TiO
2. Animals were initially treated with a single dose of 7,12-dimethylbenz[a]anthracene (DMBA) and then with 0, 10, or 20 mg sTiO
2 (mice) or 0, 50, or 100 mg ncTiO
2 (rats). The incidence and multiplicity of skin tumors (squamous cell papilloma and carcinoma) did not increase over DMBA alone controls in skin carcinogenesis-sensitive mice or rats or wild-type animals. Analysis of rat skin indicated that sTiO
2 and ncTiO
2 did not penetrate though either healthy or damaged skin. Furthermore sTiO
2 did not penetrate an
in vitro human epidermis model. Our results indicate that treatment with sTiO
2 or ncTiO
2 did not promote skin carcinogenesis in mice or rats, probably due to lack of penetration through the epidermis.
抄録全体を表示